S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
Olympic track uniforms spark online debate about who designed them and why they're so skimpy

Esperion Therapeutics (ESPR) Insider Trading & Ownership

$2.14
-0.17 (-7.36%)
(As of 04/12/2024 ET)

Esperion Therapeutics (NASDAQ:ESPR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.60%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$37,729.41
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$4,470.33
Get ESPR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Esperion Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ESPR Insider Buying and Selling by Quarter

Esperion Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/20/2023Eric WarrenInsiderSell742$1.25$927.50  
8/18/2023Eric WarrenInsiderSell243$1.41$342.63  
7/19/2023Eric WarrenInsiderSell106$1.58$167.48  
6/21/2023Eric WarrenInsiderSell603$1.48$892.44  
5/17/2023Eric WarrenInsiderSell219$1.62$354.78  
5/10/2023J Martin CarrollDirectorBuy8,409$1.49$12,529.41  
5/9/2023Sheldon L KoenigCEOBuy20,000$1.26$25,200.00  
4/19/2023Benjamin LookerGeneral CounselSell1,290$1.27$1,638.30  
4/19/2023Eric WarrenInsiderSell115$1.28$147.20  
(Data available from 1/1/2013 forward)

ESPR Insider Trading Activity - Frequently Asked Questions

Who is on Esperion Therapeutics's Insider Roster?

The list of insiders at Esperion Therapeutics includes Benjamin Looker, Eric Warren, J Martin Carroll, Joanne M Foody, Sheldon L Koenig, and Target N V Biotech. Learn more on insiders at ESPR.

What percentage of Esperion Therapeutics stock is owned by insiders?

0.60% of Esperion Therapeutics stock is owned by insiders. Learn more on ESPR's insider holdings.

Which Esperion Therapeutics insiders have been buying company stock?

The following insiders have purchased ESPR shares in the last 24 months: Eric Warren ($7,460.00), J Martin Carroll ($12,529.41), and Sheldon L Koenig ($75,114.80).

How much insider buying is happening at Esperion Therapeutics?

Insiders have purchased a total of 38,015 ESPR shares in the last 24 months for a total of $95,104.21 bought.

Which Esperion Therapeutics insiders have been selling company stock?

The following insiders have sold ESPR shares in the last 24 months: Benjamin Looker ($46,067.30), Eric Warren ($34,084.79), Joanne M Foody ($47,898.86), and Sheldon L Koenig ($86,258.52).

How much insider selling is happening at Esperion Therapeutics?

Insiders have sold a total of 45,889 Esperion Therapeutics shares in the last 24 months for a total of $214,309.47 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:ESPR) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners